Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6], Unconjugated, Human

Catalog Number: BYT-ORB1274613
Article Name: Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6], Unconjugated, Human
Biozol Catalog Number: BYT-ORB1274613
Supplier Catalog Number: orb1274613
Alternative Catalog Number: BYT-ORB1274613-0.1
Manufacturer: Biorbyt
Host: Human
Category: Antikörper
Application: ELISA
Species Reactivity: Virus
Immunogen: full length recombinant Nucleocapsid Protein
Conjugation: Unconjugated
Alternative Names: N protein, Nucleocapsid Phosphoprotein, Nucleocapsid protein, SARS-CoV-2 (COVID-19) Nucleocapsid Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), covid-19, sars-cov-2
Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6]
Clonality: Recombinant
Concentration: 5.0 mg/ml (+/- 10 %)
Clone Designation: [4A6]
NCBI: 43423
UniProt: P0DTC9
Buffer: PBS, pH 7.4
Form: Liquid
Target: N
Application Notes: Application Notes: Immunoreactivity: 80-120 % compared to the reference sample in an ELISA test
Immobilized 2019-nCoV Nucleocapsid Protein (Catorb1228242) at 5.0µg/ml (100µL/well) can bind Recombinant anti-2019-nCoV NP ScFv (4A6), the EC50 is less than 6.65ng/ml.
Stability is confirmed by binding ability with 2019-nCoV Nucleocapsid Protein (Catorb1228242). The result showed that product bioactivity is no significant differences among these samples.
Please note that pair recommendations are based on results obtained by our laboratory. Equally good results may be obtained using other pairs and therefore these recommendations are only indicative.
Freeze-thaw stability is tested by repeated freeze-thaw cycles. The result showed that product bioactivity is no significant differences after freeze-thawing 14 times.